Hemogenyx Pharmaceuticals PLC (HEMO) — Cash Flow Reinvestment Rate
Hemogenyx Pharmaceuticals PLC (HEMO) has a Cash Flow Reinvestment Rate of 0.47x as of June 2017, reinvesting GBX11.02 (capex GBX11.02 ) from operating cash flow of GBX23.26. Explore HEMO capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hemogenyx Pharmaceuticals PLC Cash Flow Reinvestment Rate (2015–2015)
Historical reinvestment intensity for Hemogenyx Pharmaceuticals PLC across 1 annual periods. Also explore HEMO total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hemogenyx Pharmaceuticals PLC (2015–2015)
Year-by-year capital reinvestment analysis for Hemogenyx Pharmaceuticals PLC. For live market cap and broader valuation context, see Hemogenyx Pharmaceuticals PLC market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2015 | 0.00x | GBX0.00 | GBX79.71 | GBX0.00 | — |